I

Iovance Biotherapeutics

D
IOVA
USD
0.425
(3.5865%)
Market Closed
380,088.00
Volume
-1.49
EPS
-
Div Yield
-6.688623
P/E
3,725,632,778.80
Market Cap
Today
1.0704%
1 Week
17.577%
1 Month
22.873%
6 Months
-12.259%
12 Months
183.815%
Year To Date
51.077%
All Time
49.149%

Title:
Iovance Biotherapeutics

Sector:
Healthcare
Industry:
Biotechnology
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
Do you need help or have a question?